LabCentral 238 Opens with Focus on Scale-Up Bio-Manufacturing
Kendall Square's first co-working lab and bio-manufacturing space is based on founding sponsorships from Astellas Pharma Inc. and the Massachusetts Life Sciences Center (MLSC)
CAMBRIDGE, Mass., Oct. 6, 2022 /PRNewswire/ -- LabCentral, the first-of-its-kind shared laboratory space designed as a launchpad for high-potential biotech startups, today announced the grand opening of LabCentral 238, its newest facility in Kendall Square that is focused on scale-up bio-manufacturing.
Massachusetts Lt. Governor Karyn Polito along with representatives from Astellas and LabCentral will be discussing the news at a facility grand opening event at 10 a.m. at LabCentral 238.
A private, non-profit institution, LabCentral was founded in 2013 as a launchpad for high potential life-sciences and biotech startups. Operating a total of 150,000 square-feet in the heart of Kendall Square in Cambridge, Mass., LabCentral offers fully permitted laboratory and office space for as many as 76 startups comprising approximately 600 scientists and entrepreneurs. More information is available at www.labcentral.org.
View original content to download multimedia:https://www.prnewswire.com/news-releases/labcentral-238-opens-with-focus-on-scale-up-bio-manufacturing-301642397.html
IDEA SHOWCASE RECEPTION AND PITCH EVENT - Open to all Badge Holders - Sponsored by RingLogix
Cryptocurrency Litigation - Yesterday, Today, and Tomorrow